▶ Watch ↗AI Engineer World's Fair 202528:04
Conference affiliation: Novartis · 2025
Hubert Misztela is a director of data science at Novartis working on generative molecular design, scientific reasoning and enterprise AI. He has helped create influential research tools for drug discovery while developing approaches that combine language models, specialized software and human expertise.
Misztela began in computer science and cryptography, coauthoring research on private information retrieval using trusted hardware. His later research brought machine learning into pharmaceutical discovery, where he has led AI researchers working on drug design.
In 2021, he coauthored FS-Mol, a molecular dataset and benchmark for few-shot learning in drug discovery, designed around a central pharmaceutical constraint: experimental measurements for individual biological targets are often scarce. His subsequent work included molecular-graph reconstruction with variational autoencoders and PREFER, a predictive-modeling framework for molecular discovery.
He also coauthored Chimera, a retrosynthesis-prediction framework that combines chemically complementary models through learned ensembling. The project addresses a practical limitation of computational drug design: a promising molecule is valuable only when researchers can identify plausible ways to make it.
▶ Watch ↗AI Engineer World's Fair 202528:04
▶ Watch ↗AI Engineer World's Fair 202420:00
Loading more talks and highlights…